Sargent Bickham Lagudis LLC Nov Access Global Inc. Transaction History

Sargent Bickham Lagudis LLC

  • $1.22 Billion
  • Q4 2022

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Sep 13, 2021
SELL
$0.9 - $1.9 $2,047 - $4,322
-2,275 Closed
0 $0
Q2 2018

Sep 13, 2021
BUY
$0.8 - $2.8 $1,820 - $6,370
2,275 New
2,275 $0

About NovAccess Global Inc.

XSNX Quotes by TradingView
  • Ticker XSNX
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,534,100
  • Description
  • NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio.
More about XSNX
Track This Portfolio

Track Sargent Bickham Lagudis LLC Portfolio

Follow Sargent Bickham Lagudis LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email